Boots

Key Findings

• Settlements: A May 2008 Jewish Chronicle report said Ahava, a Dead Sea cosmetics maker whose production was historically sited at the West Bank settlement of Mitzpe Shalem, “already supplies Boots”.^{1, 2} A July 2008 BDS page says Boots no longer stocked Ahava, with no reason given.³ Current stocking status is unresolved.
• Economic: In 2008 Boots said it did not operate any pharmacy or wholesale activity in Israel. It neither confirmed nor denied reported talks to franchise the New Pharm chain, and no completion has been identified.¹
• Political: The audits identify no Boots or WBA statement on Israel or Palestine beyond that 2008 response, and no lobbying or donation record tied to Israel/Palestine policy.¹
• Not found: No public evidence identified of any Boots contract with the Israeli military, or of an Israeli-origin technology vendor in its documented stack. Its UK defence links are HR and employer-recognition schemes only.^{4, 5, 6}

Target Profile

Key Facts:

• The Companies House PSC chain is Boots UK Limited → Alliance Boots Holdings Limited → WBA Acquisitions UK Holdco 7 Limited, all notified 6 April 2016. It has not been updated for the 2025 or 2026 transactions.^{12, 13}
• The Wittington/Fairfax purchase price is approximately US$8.9bn including assumed debt, with Q1 2027 completion expected.^{10, 9}
• The WBA/Sycamore deal was valued at up to $23.7bn per WBA’s own SEC filing.¹⁴

Executive Summary

The audits document a narrow Israel/Palestine nexus for Boots, resting almost entirely on 2008 reporting. The Jewish Chronicle (23 May 2008) reported that Boots was “understood to be negotiating” to rebrand the Israeli chain New Pharm as “Boots Israel”. It also said Ahava Dead Sea Laboratories already supplied Boots, and that a Boots delegation of roughly 10–11 people would visit Tel Aviv in June 2008.¹ Boots’ on-record reply was that it did “not operate any pharmacy or wholesale activity at present in Israel” and did not comment on market speculation.¹ No source confirms the franchise plan was completed.¹

The strongest settlement-related vector is Ahava, whose manufacturing was historically at Mitzpe Shalem, a West Bank settlement.² The only evidence that Boots stocked it is the 2008 reporting. A BDS page from July 2008 says a customer-service enquiry found Boots “no longer stocks” Ahava, which sits in tension with the Jewish Chronicle’s “already supplies Boots”; the audits found no resolution.^{3, 1} A June 2026 Superdrug episode over Ahava does not mention Boots.¹⁵ No post-2008 evidence either way was obtained on Boots and Ahava, so the current position is unknown.

Not supported by evidence: any contract with the Israeli Ministry of Defence or IDF, any dual-use or weapons involvement, any Israeli-origin technology vendor, any Israeli subsidiary, or any Boots statement on the conflict. Boots’ UK defence relationships (the Armed Forces Covenant and the Defence Employer Recognition Scheme Gold Award) are HR and employer-recognition arrangements, not procurement.^{16, 4, 5} Boots’ UK retail-crime and facial-recognition links (Operation Pegasus funding, Auror) are domestic with no identified Israeli nexus.^{6, 17}

The resulting scores are Economic 3.25 and Political 3.25, with Military and Digital at 0.00, giving BRS 289 (Tier D, Moderate Complicity). Both non-zero scores rest on a single reported 2008 association and carry the settlement-nexus minimums for Impact and Proximity, with Magnitude held low.

Timeline of Relevant Events

Corporate Overview

Boots UK Limited was incorporated on 11 March 1968, formerly Boots The Chemists Limited until 1 October 2007.⁷ It became part of Walgreens Boots Alliance on 31 December 2014. WBA was acquired by an affiliate of Sycamore Partners in August 2025, and The Boots Group was constituted as the post-closing structure.^{20, 8} The pending Wittington/Fairfax deal covers UK and Ireland retail, Boots Opticians, No7 Beauty Company and the Thailand and franchise businesses. Farmacias Benavides and Alliance Healthcare Deutschland are excluded.^{10, 9}

On Israeli entities: WBA’s FY2023 significant-subsidiary list names no Israeli subsidiary, though smaller subsidiaries are omitted so a minor one cannot be ruled out.¹⁴ No public evidence identified of any Boots retail, pharmacy, wholesale or franchise operation in Israel or the occupied territories. The Gulf franchise footprint (M.H. Alshaya) rests on unfetched snippets and job postings and has no identified Israeli element.^{21, 22} An unfetched IsraelDesks snippet claiming Boots products are sold in Israel via Super-Pharm is unverified.²³

Pessina’s post-deal stake is unresolved. Press reports range from about 30% (Financial Times, via Chain Drug Review, apparently WBA-level) to “nearly 50%” (The Times, via Retail Gazette), and no primary filing states a figure.^{24, 25} A Retail Gazette headline of August 2026 suggests the Weston offer may have been cut. It was not fetched and conflicts with the Skadden announcement, so it is carried as unresolved.²⁶

Domain Summaries

Military: Military

Mechanism of Involvement

No public evidence identified of any contract, tender, MoU or supply relationship between Boots and the Israeli MoD, IDF, Prison Service or Border Police. Searches surfaced only unrelated results, such as a UK MoD tender for literal combat boots.²⁷ The documented UK links are non-commercial: Boots signed the Armed Forces Covenant on 26 January 2023 and received the Defence ERS Gold Award in July 2025.^{16, 4, 19, 5} No public evidence identified of dual-use products, logistics services, munitions or defence-prime supply-chain ties.

Counter-Arguments and Evidence Limits

Every primary document on the UK defence relationships concerns HR and employer policy exclusively, with no commercial relationship described.^{16, 4, 5} The No7 Beauty Company’s inclusion in the ERS award rests only on Boots’ own release.^{4, 19} A claim that Boots “ships supplies for IDF soldiers” comes from a low-reliability aggregator that conflates Boots with the unrelated “Boots for Israel” footwear campaign, and it is not carried as fact.²⁸ Searches of the Israeli SIBAT defence-export directory found no mention of Boots, but the directory PDFs themselves were not opened, so this is a snippet-level absence.²⁹ Searches for Israel/defence ties to Barra, Hemmerdinger, Baldock and Sycamore Partners were not completed.

Named Entities and Evidence Map

UK MoD / RFCA (Covenant, ERS)^{16, 4, 5}; Steve Ager (signatory)¹⁶; unrelated “Boots for Israel” campaign²⁸. Score: I 0.0, M 0.0, P 0.0, V 0.00.

Digital: Digital

Mechanism of Involvement

Boots’ documented stack involves IBM, Xansa, Cegedim, Northgate HR, LiveRamp/Criteo and Microsoft Azure (via former parent WBA).^{30, 31} No public evidence identified of any Israeli-origin vendor, including Check Point, Wiz, SentinelOne, CyberArk, NICE, Verint or Palo Alto Networks. No public evidence identified of Boots or WBA data centres in Israel, Project Nimbus participation, or an Israeli R&D centre.

Boots funded Operation/Project Pegasus (£800,000 in 2023), described by the Surrey PCC as using CCTV and facial recognition.^{6, 32} Boots has used the Auror crime-intelligence platform since 2023.¹⁷ A Freevacy summary of a paywalled FT article lists Boots among four retailers using “Auror technology”, which includes retrospective facial recognition.³³ Boots is not named as a user of Auror’s branded Subject Recognition product.³⁴ All of this is UK domestic policing and retail-crime activity, and Auror is New Zealand-headquartered.

Counter-Arguments and Evidence Limits

The facial-recognition link is confirmed only at scheme level, with no document tracing a Boots image through matching. The Auror performance figures come solely from the vendor’s own page.¹⁷ The Freevacy item is a secondary summary of a paywalled source.³³ The 2019 Microsoft–WBA Azure partnership is snippet-level evidence, and it is unconfirmed whether Boots UK is covered or whether any innovation centre was in Israel.³¹ The 2023 payroll-provider breach (Zelis/MOVEit) has no Israeli nexus.³⁵ An Osirium contract lead could not be fetched and is unresolved.

Named Entities and Evidence Map

Auror¹⁷; Operation Pegasus^{6, 32}; LiveRamp/Criteo³⁰; Microsoft³¹; Zelis³⁵. Score: I 0.0, M 0.0, P 0.0, V 0.00 (no mechanically eligible frame).

Economic: Economic

Mechanism of Involvement

The Jewish Chronicle named Ahava as a supplier that “already supplies Boots” and CTS Chemical Industries as a supplier for the 2008 Tel Aviv visit.¹ The BDS page alleges possible expansion of sourcing from further Israeli firms (Hlavin, Ein Gedi, NanoDerma, Card Guard, Second Opinion, TransPharma, Tulip Medical). This is campaign-page characterisation, not corporate confirmation.³ Ahava’s manufacturing at Mitzpe Shalem is described as a settlement operation.² No public evidence identified that these supplier relationships continued after 2008. The reported New Pharm franchise talks were never confirmed as completed.¹

Counter-Arguments and Evidence Limits

Boots stated in 2008 that it operated no Israeli pharmacy or wholesale business.¹ The BDS page reports that Boots had dropped Ahava, and no source shows it resumed stocking.³ The 2008 New Pharm partner no longer exists under that name.¹⁸ No public evidence identified of Boots selling settlement-labelled or mislabelled goods.¹ Boots is not named in the 2026 Superdrug/Ahava reporting, in Who Profits’ Mehadrin profile, or in 2026 Israeli agricultural-export reporting.¹⁵ The Ahava/Fosun UN-database addition rests on a secondary report because the OHCHR page could not be fetched. A Who Profits search for Boots was inconclusive, and the AFSC database query returned a 404, so neither presence nor absence was confirmed on those databases. The Haaretz original is unverified.

Named Entities and Evidence Map

Ahava (Mitzpe Shalem)^{1, 2}; CTS Chemical Industries¹; New Pharm / Shufersal “Be”^{1, 18}; Sycamore, Pessina family, Wittington, Fairfax (ownership only, no Israel detail identified)^{9, 14}. Score: I 6.5, M 3.5, P 7.5, V 3.25. The examiner kept Magnitude consistent with the single-association basis used in Political.

Political: Political

Mechanism of Involvement

Boots’ only on-record statement bearing on Israel is its May 2008 reply to the Jewish Chronicle.¹ The settlement-nexus frame is the previously stocked Ahava made at Mitzpe Shalem, with Boots as the stocking channel.^{1, 2} The examiner found Business-as-Usual unsupported because no corporate communication presents Israel as an ordinary market. Impact is therefore the settlement-nexus minimum (6.5), with Magnitude Sporadic/Niche (3.5) given a single reported 2008 association. No public evidence identified of Boots or WBA lobbying, PAC spending or financing tied to Israel/Palestine policy.

Counter-Arguments and Evidence Limits

Boots’ Modern Slavery Statement and ESG page contain no Israel/Palestine content, and the Boots Charitable Trust FY2025 accounts show UK-focused giving with no Israel/Palestine reference.^{36, 20} These are document-scoped absences, not endorsements. Searches for Pessina, Wentworth and Prem Watsa found no Israel-related ties, but are not exhaustive. Galen Weston, Wittington and George Weston Limited were not checked, so that gap is open rather than a finding of absence. The Impact and Technical Reports 2025 were not opened.

Named Entities and Evidence Map

Boots / WBA¹; Mitzpe Shalem²; Superdrug (comparator)¹⁵; Pessina, Barra, Baldock, Watsa, Weston (no Israel ties identified, searches partial)¹¹. Score: I 6.5, M 3.5, P 7.5, V 3.25.

Complicity Index Score

Method: V6.6 (vetted).

• V_MAX: 3.25 Avg_OTHERS: 1.08
• BRS Score: 289 Tier: D (Moderate Complicity)

V_MAX is driven by the settlement-nexus minimum Impact of 6.5, scaled by Magnitude 3.5 (V = 6.5 × 0.5 × 1 = 3.25), and the same settlement association is counted in both Economic and Political. Tier D follows from a single low-magnitude 2008 association with no military or digital component. The method is scale-free, evidence-only and examiner-vetted.

Methodology Note

• Evidence-only: every claim traces to the four domain audits, and “No public evidence identified” is used where checks found nothing.
• Scale-free scoring: Impact reflects activity type, Magnitude reflects scale, and Proximity reflects directness.
• Temporal rule: divested, exited or discontinued operations are mitigated, and the BDS page’s report that Boots stopped stocking Ahava is carried as unresolved.
• Entity attribution: there is no transitive guilt. Owners and investors are recorded only where the audits document them, and the unrelated “Boots for Israel” campaign was excluded.
• Settlement operations are counted in both Economic and Political.
• Unverified, snippet-only and conflicting items (Pessina’s stake, the August 2026 Retail Gazette headline, the Super-Pharm claim) are labelled as such and not hardened.